Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 723.00
-16.95 (-2.29%)
Jul 13, 2026, 3:24 PM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 8.51 billion as of July 13, 2026. Its market cap has decreased by -24.53% in one year.
Market Cap
8.51B
Enterprise Value
8.60B
Revenue
8.54B
Ranking
n/a
PE Ratio
18.63
Stock Price
723.00
Market Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 8.51B, an increase of 221.59%. That is a compound annual growth rate of 45.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 8.51B | 3.97% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
| May 29, 2023 | 2.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 12.32B |
| Infinium Pharmachem | 3.20B |
| Quest Laboratories | 1.49B |
| Sotac Pharmaceuticals | 1.11B |
| Zenith Drugs | 842.01M |
| Vilin Bio Med | 641.70M |
| Medicamen Organics | 260.33M |
| Sunrest Lifescience | 152.77M |